New treatment shows promise against peanut allergy
In a first, an oral immunotherapy drug derived from peanut protein could help build tolerance and eliminate potentially deadly reactions in children and adolescents with severe peanut allergies. The study showed that controlled ingestion of the medication, called AR101, derived from peanut protein, could build tolerance as well as reduce severe allergy symptoms . "Almost 6 million American children are currently living with a life-threatening food allergy," said Christina Ciaccio, Associate Professor from the University of Chicago in the US. "Every three minutes a food allergy reaction sends someone to the emergency room, contributing to the total annual cost of caring for children with food allergy to nearly $25 billion. Despite this, not a single treatment for food allergy has been approved by the FDA," she said. However, the drug "is not a quick fix, and it doesn't mean people with peanut allergy will be able to eat peanuts when
